Literature DB >> 30231243

FSCN1 Promotes Epithelial-Mesenchymal Transition Through Increasing Snail1 in Ovarian Cancer Cells.

Jie Li1, Songlin Zhang2, Meili Pei1, Lei Wu1, Yanli Liu1, Huijin Li3, Jiaojiao Lu4, Xu Li4.   

Abstract

BACKGROUND/AIMS: Epithelial-mesenchymal transition (EMT) is one of the key mechanisms mediating cancer progression. Snail1 has a pivotal role in the regulation of EMT, involving the loss of E-cadherin and concomitant upregulation of vimentin, among other biomarkers. We have found FSCN1 promoted EMT in ovarian cancer cells, but the precise mechanism of FSCN1 in EMT process has not been clearly elucidated.
METHODS: The levels of FSCN1 and snail1 were determined in epithelial ovarian cancer(EOC) specimen and in ovarian cancer cells by RT-qPCR. The changes of EMT makers and effects on snail1 by FSCN1 were examined by overexpression or depletion of FSCN1 in EOC cells by RT-qPCR and western blotting. The invasiveness of the FSCN1-modified EOC cells was examined in transwell assay. Co-immunoprecipitation (IP) was performed to detect the interaction between snail1 and FSCN1 in EOC cells.
RESULTS: We found FSCN1 and snail1 significantly increased in EOC, and especially in EOC with metastasis. FSCN1 was positively correlated with snail1 expression at the cellular/histological levels. Moreover, we further showed that FSCN1 physiologically interacted with and increased the levels of snail1 to promote ovarian cancer cell EMT.
CONCLUSION: FSCN1 promote EMT through snail1 in ovarian cancer cells. FSCN1 is an attractive novel target for inhibiting invasion and metastasis of EOC cells.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Epithelial-mesenchymal transition; FSCN1; Ovarian cancer; Snail1

Mesh:

Substances:

Year:  2018        PMID: 30231243     DOI: 10.1159/000493622

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  9 in total

1.  LncRNA CRNDE promotes cell proliferation, migration and invasion of ovarian cancer via miR-423-5p/FSCN1 axis.

Authors:  Qiong Wang; Ling-Xiong Wang; Chun-Yan Zhang; Nan Bai; Chen Feng; Zhuo-Mei Zhang; Liang Wang; Zhen-Zhen Gao
Journal:  Mol Cell Biochem       Date:  2022-02-15       Impact factor: 3.396

2.  FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway.

Authors:  Minghui Li; Zhiming Gao; Honglin Ding; Zhanhua Wang; Hada Mu; Lei Zhang; Jiufu Wei; Zhanshu Ma
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-29       Impact factor: 2.650

3.  Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway.

Authors:  Yiming Jia; Jingru Li; Jinfeng Wang; Tianjiao Luo; Xiaoqian Jing; Hongmin Zhao
Journal:  Anal Cell Pathol (Amst)       Date:  2022-05-13       Impact factor: 4.133

4.  SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF.

Authors:  Weikai Xiao; Shaoquan Zheng; Xinhua Xie; Xing Li; Lijuan Zhang; Anli Yang; Jian Wang; Hailin Tang; Xiaoming Xie
Journal:  Mol Ther Oncolytics       Date:  2020-03-13       Impact factor: 7.200

5.  GRHL3 activates FSCN1 to relax cell-cell adhesions between migrating keratinocytes during wound reepithelialization.

Authors:  Ghaidaa Kashgari; Sanan Venkatesh; Samuel Refuerzo; Brandon Pham; Anita Bayat; Rachel Herndon Klein; Raul Ramos; Albert Paul Ta; Maksim V Plikus; Ping H Wang; Bogi Andersen
Journal:  JCI Insight       Date:  2021-09-08

6.  Transcriptome analysis reveals the potential biological function of FSCN1 in HeLa cervical cancer cells.

Authors:  Fengqin Guo; Yanliang Liu; Yanxiang Cheng; Qifan Zhang; Weili Quan; Yaxun Wei; Li Hong
Journal:  PeerJ       Date:  2022-02-02       Impact factor: 2.984

7.  Biomarkers of non-communicable chronic disease: an update on contemporary methods.

Authors:  Solaiman M Al-Hadlaq; Hanan A Balto; Wail M Hassan; Najat A Marraiki; Afaf K El-Ansary
Journal:  PeerJ       Date:  2022-02-24       Impact factor: 3.061

8.  Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States-Based Subtyping in Bladder Cancer.

Authors:  Rixin Hu; Tao Tao; Lu Yu; Qiuxia Ding; Guanghui Zhu; Guoyu Peng; Shiwen Zheng; Leyun Yang; Song Wu
Journal:  Front Cell Dev Biol       Date:  2022-02-09

Review 9.  How does fascin promote cancer metastasis?

Authors:  Shengchen Lin; Matthew D Taylor; Pankaj K Singh; Shengyu Yang
Journal:  FEBS J       Date:  2020-07-23       Impact factor: 5.542

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.